-
Alleged Rihanna mansion shooter mentally fit for trial, says judge
-
Hurricane Polo sweeps over Mexico's Pacific coast
-
Mystery over UK airbase scare as police find petrol not explosives
-
Man City must be relegated after guilty verdict says club's former chairman
-
OpenAI unveils low-cost AI model, a day after shelving Astra upgrade
-
German far-right aims to lead Saxony-Anhalt govt in December
-
Premier League confirms Man City guilty of serious financial breaches
-
Little damage as Hurricane Polo sweeps over Mexico's Pacific coast
-
Brazil's Lula turns to Bad Bunny tune to criticise Trump ahead of polls
-
Manchester City guilty of breaking financial rules - Premier League
-
Nigerian dancer eyes world record after seven-day marathon
-
FIFA boss Infantino blasted as would-be 'emperor' by UEFA's Ceferin
-
Swiss regulator concludes Julius Baer bank probe
-
Stocks move lower despite oil prices dropping
-
Brazil's patron saint pulled into latest election scrap
-
AI driving up innovation investment: UN
-
Football overload leaves players near 'breaking point', warns Tebas
-
UN Security Council extends Haiti mission by 6 months
-
Paris Eiffel Tower says chief to step down after uproar over removing women staff
-
Man Utd do not deserve medals if Man City stripped of titles: Rooney
-
Amaze Holdings (NYSE: AMZE) Executes Binding LOI to Acquire BullionFX | Alchemy, a Decentralized Gold-Backed Financial Ecosystem for Valued at US$155 Million
-
Vana Completes Expanded Staking as Part of the Vega Upgrade, Publishes Expanded VANA Token Economics
-
Clashes between French teens, police as school blockades intensify
-
Spain to cap gas price hikes, extend fuel discounts
-
Stocks move sideways despite oil moving lower
-
'We just need rain': Germany's Rhine river hits new low
-
African leaders to gather in Egypt for business summit
-
Yemen health system at 'breaking point': WHO
-
UK decides against charging foreign visitors for museums
-
Ireland undecided on second Israel match: coach
-
Dallaglio to sell England World Cup winners' medal
-
France's Le Pen defiant after top ally hit by antisemitism claims
-
Brazil come from behind to beat Australia 4-2 in friendly
-
Tom Cruise trades stunts for satire as toxic tycoon 'Digger'
-
Ruthless An retains Asian Games badminton crown as Kunlavut triumphs
-
MEXC Unveils "WE SEE YOU" Brand Visual Refresh, Putting People Behind Every Trade in Focus
-
Alonso to stay with F1 team Aston Martin in 2027
-
Thai capital cleans up after deadly floods
-
China badminton 'still strong' despite Asian Games slump
-
NATO, EU allies rally to Estonia after 'sabotage' blamed on Russia
-
'Exceptional' Turner painting shown in Rome before sale
-
Families demand justice for Cameroon's 'nightmare' wave of murdered women
-
European stocks climb as oil dips
-
Tebas says Man City should face 'most severe' sanctions if guilty of rule breaches
-
Spain aims to ban evictions until 2030 amid housing protests
-
Pochettino calls Man City success 'a period of deception'
-
Kunlavut first Thai man to win Asian Games badminton singles gold
-
Settler attack on West Bank village injures Israeli forces, drawing rare rebuke
-
French far right says antisemitism claims part of 'total war' to derail presidency bid
-
Mystery over UK airbase scare after reports no explosives found
Trump announces drug prices cut with swipe at Europe
US President Donald Trump said Monday he would slash drug prices so that they match costs abroad, accusing the "brutal" European Union in particular of forcing pharmaceutical firms to lower prices on its turf.
Trump claimed as he signed the executive order at the White House that drug prices should fall by at least 59 percent -- and in some cases as high as 80 or 90 percent.
Under the plan, Trump aims to institute a "Most Favored Nation" policy that pins the cost of drugs sold in the United States to the lowest price paid by other countries for the same drug.
"Whoever is paying the lowest price, that's the price that we're going to get," Trump said.
The US president's plan will count mainly on the goodwill of pharmaceutical companies to negotiate their prices and could face legal challenges, as did a similar proposal Trump pushed during his first term.
Trump said American consumers had been treated like "suckers" and cited in particular the costs of the obesity-reducing drug Ozempic, which he said were vastly higher in Europe.
He blasted the European Union nation in particular over drug prices, alleging that the 27-nation bloc forced pharmaceutical firms to lower their costs on their territory.
"It was really the countries that forced Big Pharma to do things that, frankly, I'm not sure they really felt comfortable doing, but they've gotten away with it," Trump said.
"The European Union has been brutal, brutal. And the drug companies actually told me stories it was just brutal, how they forced them."
- 'Powerful lobby' -
Trump said he would also order an investigation into countries that "extort" drug companies by "blocking their products" unless they accepted low prices.
But Trump added that he was also "doing this against the most powerful lobby in the world -- the drug and pharmaceutical lobby."
Health Secretary Robert Kennedy Jr, who has caused controversy for his skepticism over vaccinations, praised the plan.
"There has never been a president more willing to stand up to the oligarchs than Donald Trump," Kennedy said as he stood next to the billionaire property developer.
Trump had trailed the announcement of the 59 percent cut earlier on Monday.
"DRUG PRICES TO BE CUT BY 59%, PLUS! Gasoline, Energy, Groceries, and all other costs, DOWN. NO INFLATION!!!" Trump posted on his Truth Social platform.
The reduction in prescription drug costs in the United States would, he added in his post, be counterbalanced by higher costs in other countries.
"Most favored nation" status is a World Trade Organization rule that aims to prevent discrimination between a country and its trading partners, levelling the playing field for international trade.
This is not the first time that Trump has attempted to lower US drug prices.
During his first 2017-2021 term in office, he announced a similar proposal to cut US drug prices but his plans failed in the face of strong opposition from the pharmaceutical industry.
Last month, the US president signed an executive order aiming to lower crippling drug prices by giving states more leeway to bargain-hunt abroad and improving the process for price negotiations.
T.Wright--AT